Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 22 Results

Intervention Indication Therapeutic Area Year Actions
Tanezumab for cancer pain due to bone metastasis Tanezumab (PF-04383119; RN624) Cancer pain Bone and Cartilage Cancer , Oncology 2020 View  |  Download
TAS-102 with bevacizumab for treating refractory metastatic colorectal cancer after 2 previous therapies Bevacizumab (Avastin; R 435; RG 405; RG 435) , Lonsurf; TAS-102 (fixed dose combination: Trifluridine; Tipiracil hydrochloride) Colorectal cancer Gastrointestinal Cancer , Oncology 2023 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications